Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 2147

PDF Downloaded: 1055


Get Permission Kamble, Nagalakshmi N C, Raunakkumar, Verma, and Pardhe: A review of ancient medicinal plants utilized in therapy of cardiovascular diseases


Introduction

The cardiovascular system facilitates nutrients, oxygen, and directly influences the consistency of body tissues, organs, and phrenic condition to be provided to body systems. The class of diseases affecting the heart or blood vessels (arteries, capillaries and veins) is cardiovascular disorder.1 Cardiovascular disease (CVD) leads to death, generally speaking. In addition, Expand nations such as India, along with the growing burden of excessive corpulence, type II diabetes and hypertension, are struggling to manage the impact of CVD.2 Heart disease occurs 10 to 15 years earlier in India than in the West. Coronary heart disease causes one-fifth of deaths in India (CHD). It will account for one third of deaths by the year 2020. Common estimates indicate that India will have the most tremendously colossal CVD burden in the world by 2020.3 In the treatment of patients with congestive heart failure, systolic hypertension, angina, atherosclerosis, plant or herbal diseases have been used for cardiovascular diseases. The effectiveness of plant sterols and stanols have been shown to reduce cholesterol and, as such, to truncate contingency for heart disorders.4 Cardiovascular diseases (CVDs) were paramount for the largest number of deaths in 2019, according to estimates from the World Health Organization.5 A sultry issue in the field of CVD is discovering safe and efficient drugs that accumulate from natural products.6 Because of their safety profiles, medicinal plants have important advantages for the treatment of cardiovascular disease.7 Patients with cardiovascular diseases who have been told of the benefits of medicinal plants may improve their health. For example, medicinal plant-containing diets may be used to effectively regulate hypertension.8 The world's first cause of death is cardiovascular disease (CVDs).9 An estimated 17.5 million individuals died in 2012 from CVDs, representing 31% of all ecumenical deaths. Coronary artery disease (7.4 million deaths, CVD deaths) and stroke (6.7 million deaths, CVD deaths) are the core diseases of CVDs.9, 10 Popularity increases from 5% at 20 years of age to 75% at 75 years of age.11 Cardiovascular disease incidence is affected by a high glycemic index (higher postprandial blood glucose and insulin levels).12

Garlic (Allium sativum L.) is a Liliaceae family edible and medicinal plant used in archaic Iranian medicine in the treatment of various diseases.13, 14 The principal utilization of this plant is a truncation of peril factors for cardiovascular diseases (aversion of thromboembolic events and Blood pressure is high).15, 16, 17, 18, 19, 20, 21 Garlic obtained by freeze-drying has a minimum 0,45% of allicin.22 As of 2015, clinical research to determine the impact of garlic consumption on hypertension has shown that garlic consumption only results in a minute reduction in blood pressure (4 mmHg),23, 24, 25 and that there is no significant long-term effect on cardiovascular morbidity and mortality.25 Three ancient Indian medical practices i.e., Tibbi, Unani and Ayurveda, made extensive utilization of garlic as a central part of the rejuvenating efficacy of plants.26 In England, garlic was utilized for toothache, constipation, dropsy and plague.

Green tea (Camellia sinensis.) it is from the genus Camellia of the Theaceae family of flowering plants. It is native to China, South and Southeast Asia on the mainland.27 Green tea contained a characteristic polyphenolic compound called catechin.Themain catechins presented were: epigallocatechin gallate (EGCG), epicatechin Augallate (ECG), epigallocatechin (EGC) and epicatechin (EC), and EGCG was the main form of tea catechin.28, 29 Green tea has been utilized as a possible treatment for ameliorating phrenic vigilance and availing in weight loss. Proposed cardiovascular effects include minimization of cholesterol levels, amended diabetes control, and aversion of cardiovascular events. Green tea is opulent in flavonoids that are mainly present as catechins.30 Over the years, there have been a variety of studies examining green tea consumption in venerating the risk of CVD.31 Two research from Japan involving approximately 50,000 individuals find a decreased mortality rate due to CVD based on intake of different numbers of cups per day. One study found that CVD death among those who consumed about 3 cups and those who consumed about 10 cups decreased by 28 percent. For those who consumed <1 cup and those who consumed <5 cups, the other study showed a 14 percent decrease in CVD mortality.32, 33

Flaxseed (Linumusitatissimmum) is known in Indian languages as Alsi, Jawas, Aksebija, and is a blue flowering rabi crop and a member of the medicinal plant of the Linaceae family. The annual engenderment of flax was 3.06 million tons and Canada is the worlds most astronomically enormous flax engenderer (approximately 38% of the global engenderment).34 In Latin word linumusitatissimum betokens “very useful”, and it has two rudimentary varieties: brown and yellow or golden (withal kenned as golden linseeds).35 Alpha-linolenic acid (ALA), lignans, fiber, and four other mundane types of flaxseed available for human consumption are among the richest sources of flaxseed, including whole flaxseed, ground flaxseed, flaxseed oil, and partially degreased flaxseed meal.36 Flaxseed protein, compared with soy protein and casein protein, is efficient in reducing plasma cholesterol and triglycerides (TAG).37 Diets high in soluble fiber may avail abbreviate the jeopardy of heart disease, diabetes, colorectal cancer, extravagant corpulence and inflammation.38

Grape seeds (Vitis viniferae) is the one of most sizably voluminous fruit crop in the world and maximum phenolic constituents are present in grape species.39 In order to play a consequential role in the prevention of cancer, cardiovascular disorders, and age-cognate ocular diseases, antioxidant vitamins and trace elements have been identified.40 The chemical composition of the grape seed contains: flavonoids (4–5%), including kaempferol-3-O-glucosides, quercetin-3-Oglucosides, quercetin and myricetin.41 Grape seed extract-victualed individuals with myocardial ischemia are resistant to injury but has cardioprotective action.42 Flavonoids in grape juice decremented the occurance of blood to clot and with customary utilization of grape juice cardiovascular disease can be suppressed and has more bulwark against heart disease than mead.43 It is widely thought that grape seed extract (GSE) has some advantage in the treatment of many cardiovascular disorders, including atherosclerosis, hypertension, hypercholesterolemia, chronic venous insufficiency, and diabetic retinopathy and neuropathy.44 Mundane side effects reported in RCTs include itching, dizziness, nausea, diarrhea, headache, sore throat, and cough.45, 46

Milk Thistle (Silybum marianum) Milk thistle is a member of the family of asters (Asteraceae or Compositae) containing thistles and daisies.47, 48 Additionally, silibinin has been demonstrated to be pharmacologically active in the cardiovascular system. This deference has been shown to exert cardioprotective properties, e.g. following cardiac myocyte injury caused by isoproterenol.49, 50 Silymarin, an amalgamation of flavonolignans consisting of 4 isomers: silibinin, isosilibinin, silichristin, and silidianin, is the active constituent of milk thistle. Most supplements are standardized based on the quality of silibinin (often referred to as silybin). In turn, both silibinin and isosilibinin are cumulations of 2 diastereomers, respectively, silibinin A and B and isosilibinin A and B.51 During gravidity and in adults older than 75 years.52, 53 Milk thistle was used safely, a mild laxative effect and gastrointestinal discomfort are the most frequently recorded adverse events.54 Milk thistle tends to be secure for use for up to 41 months.55

Table 1

Medicinal herbs used in cardiovascular disease

Activity

Name of the plants

Reduce cardiovascular risk, including abnormal plasma lipids and a high blood pressure.

Garlic

Decrease cholesterol absorption and plasma levels.

Green tea

Oxidant tension reduction, platelet adhesion, blood sugar, and blood pressure reduction.

Flaxseed oil

It improves vascular health, thus substantially reducing the risk of cardiovascular disease and hypertension.

Grape Seeds

Used safety during gravity and in adults older than 75 year.

Milk thistle

Conclusion

With the advent of a growing number of heart diseases in all age groups, it is time to explore various herbs and their preparations so that morbidity and mortality from heart diseases can be minimized in our everyday lives. The number one cause of death is cardiovascular diseases globally, and they are projected to remain so. An estimated 17 million people, representing 30 percent of all global deaths, died from cardiovascular disease in 2005. 7.2 million of these fatalities were due to heart attacks and 5.7 million were due to stroke. About 80 percent of these deaths have occurred in countries with low and medium incomes.It is estimated that 23.6 million people will die from cardiovascular disease by 2030 if current trends are allowed to continue (mainly from heart attacks and strokes). Single herb medicines are grouped here based on their properties, with particular emphasis on commonly used garlic, green tea, flaxseed, grape seeds and milk thistle.

Source of Funding

None.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

1 

S Mendis P Puska B Norrving World Health Organization. Global atlas on cardiovascular disease prevention and control. World Health Organization2011

2 

TPA Devasagayam JC Tilak KK Boloor KS Sane SS Ghaskadbi RD Lele Free radicals and antioxidants in human health: current status and future prospectsJ Assoc Physicians India200452794804

3 

J Han ML Bennish Condom Access in South African Schools: Law, Policy, and PracticePLoS Med20096110.1371/journal.pmed.1000006

4 

A Kamal-Eldin A Moazzami Plant sterols and stanols as cholesterol-lowering ingredients in functional foods. Recent Patents on FoodNutr Agriculture20091114

5 

Y Mamani-Ortiz MS Sebastián AX Armaza JM Luizaga DE Illanes M Ferrel Prevalence and determinants of cardiovascular disease risk factors using the WHO STEPS approach in Cochabamba, BoliviaBMC Public Health20191911310.1186/s12889-019-7064-y

6 

AP Slovinski LA Hajjar Can Ince Microcirculation in Cardiovascular DiseasesJ Cardiothorac Vasc Anesth20193334586810.1053/j.jvca.2019.08.008

7 

X Jin H Ge Nonequilibrium steady state of biochemical cycle kinetics under non-isothermal conditionsNew J Phys20182010.1088/1367-2630/aab8cf

8 

YQ Sun AL Jiang SM Chen H Li HY Xing F Wang Quality of life and self-care in elderly patients with cardiovascular diseases: The effect of a Traditional Chinese Medicine health educational interventionAppl Nurs Res20173813440

9 

AH Mota A review of medicinal plants used in therapy of cardiovascular diseasesInt J Pharmacogn Phytochem Res20168457291

10 

AR Ness JW Powles Fruit and vegetables, and cardiovascular disease: a review.Int J Epidemiol199726111310.1093/ije/26.1.1

11 

AH Mota A review of medicinal plants used in therapy of cardiovascular diseasesInt J Pharmacogn Phytochem Res20168457291

12 

DS Ludwig The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular diseaseJama200228718241423

13 

RA Nagourney Garlic: Medicinal Food or Nutritious Medicine?J Med Food199811132810.1089/jmf.1998.1.13

14 

E Tattelman Health effects of garlicAm Fam Physician2005721036

15 

L Bayan PH Koulivand A Gorji Garlic: a review of potential therapeutic effectsAvicenna J Phytomed201441114

16 

T Nohara Y Fujiwara R Kudo K Yamaguchi Tsuyoshi Ikeda K Murakami Isolation and Characterization of New Onionins A<sub>2</sub> and A<sub>3</sub> from <i>Allium cepa</i>, and of Onionins A<sub>1</sub>, A<sub>2</sub>, and A<sub>3</sub> from <i>Allium fistulosum</i>Chem Pharm Bull2014621141510.1248/cpb.c14-00461

17 

PF Cavagnaro CR Galmarini Effect of Processing and Cooking Conditions on Onion (Allium cepa L.) Induced Antiplatelet Activity and Thiosulfinate ContentJ Agricultural Food Chem2012608731710.1021/jf301793b

18 

AH Mota A review of medicinal plants used in therapy of cardiovascular diseasesInt J Pharmacogn Phytochem Res20168457291

19 

XJ Xiong PQ Wang SJ Li XK Li YQ Zhang J Wang Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trialsPhytomedicine201522335261

20 

DY Lee H Li HJ Lim HJ Lee R Jeon JH Ryu Anti-inflammatory activity of sulfur-containing compounds from garlicJ Med Food201215119929

21 

A Capasso Antioxidant action and therapeutic efficacy of Allium sativum LMolecules2013181690700

22 

AH Mota A review of medicinal plants used in therapy of cardiovascular diseasesInt J Pharmacogn Phytochem Res20168457291

23 

K Ried OR Frank NP Stocks P Fakler T Sullivan Effect of garlic on blood pressure: A systematic review and meta-analysisBMC Cardiovasc Disord2008811210.1186/1471-2261-8-13

24 

A Rohner K Ried IA Sobenin HC Bucher AJ Nordmann A Systematic Review and Metaanalysis on the Effects of Garlic Preparations on Blood Pressure in Individuals With HypertensionAm J Hypertens2015284142310.1093/ajh/hpu165

25 

SN Stabler AM Tejani F Huynh C Fowkes Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patientsCochrane Database Syst Rev20128CD00765310.1002/14651858.CD007653.pub2

26 

SB Moyers Garlic in health, history, and world cuisineSuncoast Press1996

27 

C Dattner The Book of Green Tea200313

28 

CS Yang J Zhang L Zhang J Huang Y Wang Mechanisms of Body Weight Reduction and Metabolic Syndrome Alleviation by TeaMol Nutr Food Res20166016074

29 

S Koo S Noh Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effectJ Nutr Biochem2007181798310.1016/j.jnutbio.2006.12.005

30 

V Stangl M Lorenz K Stangl The role of tea and tea flavonoids in cardiovascular healthMol Nutr Food Res2006502182810.1002/mnfr.200500118

31 

N Jochmann G Baumann V Stangl Green tea and cardiovascular disease: from molecular targets towards human healthCurr Opin Clin Nutr Metab Care2008117586510.1097/mco.0b013e328314b68b

32 

K Nakachi S Matsuyama S Miyake M Suganuma K Imai Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting preventionBioFactors2000131-4495410.1002/biof.5520130109

33 

S Kuriyama T Shimazu K Ohmori N Kikuchi N Nakaya Y Nishino Green Tea Consumption and Mortality Due to Cardiovascular Disease, Cancer, and All Causes in JapanJAMA20062961012556510.1001/jama.296.10.1255

34 

Anonymous. Oil world statistics updateOil World200031910

35 

JK Daun VJ Barthet TL Chornick S Duguid Structure, composition, and variety development of flaxseedFlaxseed in human nutrition200314010.1201/9781439831915.ch1

36 

M Parikh T Netticadan GN Pierce Flaxseed: its bioactive components and their cardiovascular benefitsAm J Physiol-Heart Circ Physiol20183142H1465910.1152/ajpheart.00400.2017

37 

MA Eastwood R Passmore Dietary fibreLancet (USA)1983283432026

38 

SJ Bhathena AA Ali AI Mohamed CT Hansen MT Velasquez Differential effects of dietary flaxseed protein and soy protein on plasma triglyceride and uric acid levels in animal modelsJ Nutr Biochem200213684910.1016/s0955-2863(02)00227-9

39 

S S Percival Grape consumption supports immunity in animals and humansJ Nutr2009139918015

40 

M Berger Can oxidative damage be treated nutritionally?Clin Nutr20052421728310.1016/j.clnu.2004.10.003

41 

T Escribano-Bailon Y Gutierrez-Fernandez JC Rivas-Gonzalo C Santos-Buelga Characterization of procyanidins of Vitis vinifera variety Tinta del Pais grape seedsJ Agric Food Chem199240101794910.1021/jf00022a013

42 

J Cui B Juhasz A Tosaki N Maulik DK Das Cardioprotection With GrapesJ Cardiovasc Pharmacol2002405762910.1097/00005344-200211000-00014

43 

JD Folts Potential health benefits from the flavonoids in grape products on vascular diseaseAdv Exp Med Biol200250595111

44 

AAA Bertelli DK Das Grapes, Wines, Resveratrol, and Heart HealthJ Cardiovasc Pharmacol20095464687610.1097/fjc.0b013e3181bfaff3

45 

E Park I Edirisinghe YY Choy A Waterhouse B Burton-Freeman Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trialBr J Nutr201611522263810.1017/s0007114515004328

46 

HHH Feringa DA Laskey JE Dickson CI Coleman The Effect of Grape Seed Extract on Cardiovascular Risk Markers: A Meta-Analysis of Randomized Controlled TrialsJ Am Dietetic Assoc2011111811738110.1016/j.jada.2011.05.015

47 

JM Jellin PJ Gregory Pharmacist’s Letter/Prescribers Letter Natural Medicines Comprehensive Database11th editionTherapeutic Research FacultyStockton, California2009

48 

J Pepping Milk thistle: Silybum marianumAm J Health-Syst Pharm1999561195710.1093/ajhp/56.12.1195

49 

B Zhou LJ Wu S Tashiro S Onodera F Uchiumi T Ikejima Silibinin Protects Rat Cardiac Myocyte from Isoproterenol-Induced DNA Damage Independent on Regulation of Cell CycleBiol Pharm Bull20062991900510.1248/bpb.29.1900

50 

B Zhou LJ Wu LH Li S Tashiro S Onodera F Uchiumi Silibinin Protects Against Isoproterenol-Induced Rat Cardiac Myocyte Injury Through Mitochondrial Pathway After Up-regulation of SIRT1J Pharmacol Sci200610243879510.1254/jphs.fpj06005x

51 

DY Lee Y Liu Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum m arianum (Milk Thistle)J Nat Prod200366911714

52 

R Hernández E Nazar ProductsRev Chil Obstet Ginecol1982471229

53 

H Allain S Schück S Lebreton A Strenge-Hesse W Braun JM Gandon Aminotransferase Levels and Silymarin in de novo Tacrine-Treated Patients with Alzheimer’s DiseaseDement Geriat Cogn Disord199910181510.1159/000017117

54 

R Saller R Meier R Brignoli The Use of Silymarin in the Treatment of Liver DiseasesDrugs2001611420356310.2165/00003495-200161140-00003

55 

F Rainone Milk thistleAm Fam Physician20057212858



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

1-4


Authors Details

Jayalalita Shanakka Kamble, Nagalakshmi N C, Chaurasiya Raunakkumar, Usha Verma, Harshitha Arun Pardhe


Article History

Received : 25-02-2021

Accepted : 02-03-2021


Article Metrics


View Article As

 


Downlaod Files